Morris Clare, Emsley Paulene, Marland Elizabeth, Meuleneire Frans, White Richard
North East Wales NHS Trust, Wrexham.
Paediatr Nurs. 2009 Apr;21(3):38-43. doi: 10.7748/paed2009.04.21.3.38.c7037.
To evaluate how pain, during and in-between dressing changes, is affected by the introduction of Mepilex Border Lite, a wound dressing manufactured by Mölnlycke Health Care using Safetac soft silicone adhesive technology, to the treatment of different types of paediatric wounds/skin injuries.
Wounds/skin injuries that met the criteria for inclusion in the study were dressed with Mepilex Border Lite. Patients were followed for six weeks or until their wounds/skin injuries had healed, whichever occurred earlier. At each dressing change, pain severity before and during dressing removal was rated by the patient and the investigator on a scale from zero (no pain at all) to ten (worst pain ever). Other variables measured included: signs of trauma to wound/skin injury and surrounding skin, the proportion of viable/non-viable tissue, the quantity and appearance of exudate, odour, and clinical signs of infection. At the final dressing change, patients and investigators completed questionnaires to rate the dressing performance.
Mean pain severity scores were significantly lower (p < or = 0.003) at the first dressing change than at baseline. Over 99.5 per cent of the Mepilex Border Lite dressing changes were reported to be atraumatic and more than half of the wounds healed within the study period. Conformability, ease of use, ease of removal, patient comfort, and overall experience with the dressing were rated as 'good' to 'very good' at the vast majority of final visit evaluations.
This study provides further evidence of the ability of dressings with Safetac soft silicone adhesive technology to minimise trauma and pain and demonstrates the ability of Mepilex Border Lite to overcome the clinical challenges associated with the use of dressings on the wounds/skin injuries of paediatric patients.
评估在不同类型儿科伤口/皮肤损伤的治疗中，使用莫林医疗保健公司采用Safetac软硅胶粘合剂技术生产的伤口敷料美皮康轻边敷料（Mepilex Border Lite），对换药期间及换药间隔期疼痛的影响。
符合研究纳入标准的伤口/皮肤损伤使用美皮康轻边敷料进行包扎。对患者进行为期六周的随访，或直至其伤口/皮肤损伤愈合，以先发生者为准。每次换药时，由患者和研究者按照从0分（完全无痛）至10分（有史以来最剧烈的疼痛）的量表对换药前和换药过程中的疼痛严重程度进行评分。测量的其他变量包括：伤口/皮肤损伤及周围皮肤的创伤迹象、存活/非存活组织的比例、渗出液的量和外观、气味以及感染的临床体征。在最后一次换药时，患者和研究者完成问卷以对敷料性能进行评分。
首次换药时的平均疼痛严重程度评分显著低于基线水平（p≤0.003）。据报告，超过99.5%的美皮康轻边敷料换药操作无创伤，且超过半数的伤口在研究期间愈合。在绝大多数最终访视评估中，敷料的贴合性、易用性、易去除性、患者舒适度及总体体验被评为“良好”至“非常好”。
本研究进一步证明了采用Safetac软硅胶粘合剂技术的敷料能够将创伤和疼痛降至最低，并表明美皮康轻边敷料有能力克服在儿科患者伤口/皮肤损伤上使用敷料所面临的临床挑战。
